Penumbra (PEN) Cash & Equivalents (2014 - 2026)
Penumbra's (PEN) quarterly Cash & Equivalents came in at $241.3 million in Q1 2026, down 35.84% year-on-year from $376.1 million in Q1 2025, and up 29.1% on a QoQ basis from $186.9 million in Q4 2025.
Penumbra (PEN) Cash & Equivalents (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Cash & Equivalents data on file, last reported at $241.3 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 35.84% year-over-year to $241.3 million in Q1 2026; TTM through Mar 2026 was $241.3 million, a 35.84% decrease from a year earlier, with the FY2025 full-year figure at $186.9 million, down 42.39% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $241.3 million, up from $186.9 million in the prior quarter.
- Over the last five years, Cash & Equivalents for PEN reached as high as $421.8 million in Q2 2025 and fell as low as $54.8 million in Q3 2022.
- Historically, Cash & Equivalents has averaged $199.5 million across 5 years, with a median of $186.9 million in 2025.
- Across the five-year window, Cash & Equivalents jumped 178.37% in 2024 and plunged 42.39% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $69.9 million in 2022, then soared by 139.75% to $167.5 million in 2023, then surged by 93.69% to $324.4 million in 2024, then plunged by 42.39% to $186.9 million in 2025, then advanced by 29.1% to $241.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $241.3 million in Q1 2026, $186.9 million in Q4 2025, and $321.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 241.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.29 Mn |
| Dec 31, 2025 | 186.90 Mn |
| Sep 30, 2025 | 321.03 Mn |
| Jun 30, 2025 | 421.77 Mn |
| Mar 31, 2025 | 376.05 Mn |
| Dec 31, 2024 | 324.40 Mn |
| Sep 30, 2024 | 280.48 Mn |
| Jun 30, 2024 | 288.33 Mn |
| Mar 31, 2024 | 223.11 Mn |
| Dec 31, 2023 | 167.49 Mn |
| Sep 30, 2023 | 100.76 Mn |
| Jun 30, 2023 | 114.17 Mn |
| Mar 31, 2023 | 94.69 Mn |
| Dec 31, 2022 | 69.86 Mn |
| Sep 30, 2022 | 54.84 Mn |
| Jun 30, 2022 | 58.23 Mn |
| Mar 31, 2022 | 68.16 Mn |
| Dec 31, 2021 | 59.38 Mn |
| Sep 30, 2021 | 66.29 Mn |
| Mar 31, 2021 | 55.63 Mn |